{"id":4329,"date":"2021-10-15T16:00:00","date_gmt":"2021-10-15T14:00:00","guid":{"rendered":"https:\/\/lifescience-factory.com\/?page_id=4329"},"modified":"2026-04-22T08:05:34","modified_gmt":"2026-04-22T06:05:34","slug":"community","status":"publish","type":"page","link":"https:\/\/lifescience-factory.com\/de\/community\/","title":{"rendered":"Community"},"content":{"rendered":"\n\n
\n\n \n
\n <\/a>\n <\/div>\n\n \n
<\/div>\n\n \n \n
\n \"background\"\n\n \"background\"\n \n \n <\/div>\n \n \n
\n\n
\n\n \n
\n

\n Meet our network <\/h1>\n <\/div>\n\n \n
\n\n \n

Unsere kuratierte Community hilft dir mit Vordenkern, Changemakern und Branchenexperten in Kontakt zu treten und zusammenzuarbeiten. Das Netzwerk versteht sich auf Unternehmertum und auf die Welt der Life Science. Die st\u00e4ndige interdisziplin\u00e4re Interaktion innerhalb dieses \u00d6kosystems stimuliert stets neue Denkweisen und L\u00f6sungen, die unsere Realit\u00e4t neu definieren und anregen.<\/p>\n\n \n \n \n <\/div>\n <\/div>\n <\/div>\n\n<\/div>\n\n\n\n

\n\n
\n
\n
\n

Vorstellung Start-Ups<\/h2>\n <\/div>\n <\/div>\n
\n
\n

Unsere diverse Gr\u00fcnder*innen-Community w\u00e4chst stetig an unseren beiden Standorten G\u00f6ttingen und M\u00fcnchen. Erfahre mehr \u00fcber die Start-ups und ihre Geschichten, Erfolge und Herausforderungen. Hier treffen Unternehmertum und Life Science Forschergeist zusammen, die unsere kollaborative Community t\u00e4glich bereichern.<\/p>\n <\/div>\n <\/div>\n <\/div>\n \n

\n
\n
\n
\n

lab user<\/h4>\n

myotwin<\/h2>\n <\/div>\n
\n

lab user<\/h4>\n

Avocet Bio<\/h2>\n <\/div>\n
\n

lab user<\/h4>\n

BrainQR<\/h2>\n <\/div>\n
\n

lab user<\/h4>\n

Repairon Immuno<\/h2>\n <\/div>\n
\n

lab user<\/h4>\n

Noselab<\/h2>\n <\/div>\n
\n

lab user<\/h4>\n

PhalanxNeuro<\/h2>\n <\/div>\n
\n

Maker’s Factory user alumni<\/h4>\n

Digity<\/h2>\n <\/div>\n
\n

lab user alumni<\/h4>\n

Cultimate Foods<\/h2>\n <\/div>\n
\n

lab user alumni<\/h4>\n

Ucaneo Biotech<\/h2>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
\n

lab user<\/h4>\n

myotwin<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Group\n <\/div>\n
\n

Neugestaltung der Arzneimittelentwicklung durch kontinuierliche Echtzeit- und High-Content-Analyse<\/h3>\n

Die Entwicklung und Testung neuer Arzneimittel bis hin zur Zulassung sind sehr kostenintensiv. Hinzu kommt, dass neue regulatorische Verordnungen die Anzahl an Tierversuchen in Zukunft verringern sollen. Das Biotech Start-up myotwin verwendet stammzell-basierte<\/em> Herzmuskelgewebe in einer eigens entwickelten Messinfrastruktur. Dies erlaubt einen deutlich fr\u00fcheren und umfangreichen Einblick in die menschliche Reaktion auf einen Wirkstoff. Dadurch k\u00f6nnen neue Wirkstoffe ohne Tierversuche in der Pr\u00e4klinik getestet werden und die Sicherheit in klinischen Studien erh\u00f6ht werden. myotwin nutzt seinen umfangreichen Daten auch zum Aufbau eines Digital Twin des menschlichen Herzmuskels, um zuk\u00fcnftig auch Services im Bereich der pr\u00e4diktiven Wirkstoffentwicklung anzubieten.<\/p>\n\n \n \n <\/span>Mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user<\/h4>\n

Avocet Bio<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Avocet\n <\/div>\n
\n

Pionierarbeit bei neuartigen RNA-basierten Therapeutika<\/h3>\n

Bei Avocet Bio ist unsere Mission klar: Wir wollen Neuland betreten, indem wir unsere Plattformtechnologie der RNA-Modulation als Schl\u00fcsselansatz f\u00fcr die Therapie verschiedener Krankheiten nutzen.<\/p>\n

Als Biotech-Startup gehen wir einige der dr\u00e4ngendsten globalen Gesundheitsherausforderungen an, einschlie\u00dflich respiratorischer Virusinfektionen, w\u00e4hrend wir das Potenzial der RNA-Modulation auf andere medizinische Bereiche erweitern.<\/p>\n

Unser langfristiges Ziel ist es, ein vielf\u00e4ltiges Portfolio an RNA-basierten Therapeutika aufzubauen, das bestehende Behandlungsl\u00fccken adressiert und neue, effektivere L\u00f6sungen f\u00fcr Patienten bietet.<\/p>\n\n \n \n <\/span>Mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user<\/h4>\n

BrainQR<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Logo\n <\/div>\n
\n

brainQr makes disordered proteins druggable<\/h3>\n

brainQr Therapeutics is developing next-generation therapies for major human diseases by targeting disordered proteins, a vast and previously largely undruggable class of biomolecules. Our mission is to harness cutting-edge scientific innovation to pioneer novel treatment strategies that address urgent unmet medical needs. <\/span>brainQr’s AI-IDP platform enables breakthrough therapies for dynamic disordered proteins, unlocking new possibilities in neurodegeneration and oncology.<\/span><\/p>\n\n \n \n <\/span>Mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user<\/h4>\n

Repairon Immuno<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Repairon\n <\/div>\n
\n

Repairon Immuno develops scalable, next-generation cell therapies based on iPSC technology to enhance existing and future CART cell therapies. The goal is to replace personalized and costly custom-made treatments with off-the-shelf cell therapies, making treatments faster, more cost-effective, and more widely accessible. The technology is intended for the causal treatment of autoimmune diseases and cancer.<\/span><\/p>\n\n \n \n <\/span>mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user<\/h4>\n

Noselab<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Logo\n <\/div>\n
\n

Noselab has developed a proprietary platform that makes biomarker signatures of central nervous system (CNS) diseases accessible through a previously untapped biological gateway: the brain\u2013nose interface (BNI) and nasal fluid. By enabling direct, minimally invasive access to CNS-related molecular signals, Noselab is driving a paradigm shift in understanding, diagnosing, monitoring, and treating brain diseases.<\/span><\/p>\n\n \n \n <\/span>mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user<\/h4>\n

PhalanxNeuro<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Logo\n <\/div>\n
\n

Focused on advanced diagnostic and analytics technologies for neurodegenerative diseases such as Alzheimer\u2019s, Parkinson\u2019s, and other dementias, PhalanxNeuro<\/em> leverages a proprietary platform that mimics the protein \u201cseeding\u201d mechanisms underlying these conditions. This approach enables the precise detection of disease\u2011specific biomarkers, subtypes, and co\u2011pathologies, supporting earlier and more accurate patient stratification. As a result, the company advances precision medicine approaches and the development of personalized treatments.<\/span><\/p>\n\n \n \n <\/span>mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

Maker’s Factory user alumni<\/h4>\n

Digity<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"3Digity\n <\/div>\n
\n

Digity ist ein auf die Hand spezialisiertes Technologie-Startup mit automatisierten Prozessen, um die menschliche Hand mit Exoskeletten auszustatten. Denn unsere H\u00e4nde definieren, wie wir mit der Welt interagieren. Unsere Mission ist daher sicherzustellen, dass diese immer gesund, gesch\u00fctzt und produktiv sind. Unsere Patente und eine digitale Hintergrundtechnologie erm\u00f6glichen es uns, unsere Exoskelette an unterschiedliche Bereiche anzupassen. Unser Startprodukt ARTUS adressiert den Arbeitsschutz und Ergonomie der Finger in manuellen T\u00e4tigkeiten in der Industrie und Handwerk. Das interdisziplin\u00e4re Team aus den Ingenieurswissenschaften, Orthop\u00e4dietechnik und Betriebswirtschaft ist aus einem EXIST-Forschungstransfer hervorgegangen und will aus G\u00f6ttingen heraus einen Marktf\u00fchrer aufbauen, der echte L\u00f6sungen f\u00fcr handbezogene Belange bietet.<\/p>\n\n \n \n <\/span>mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user alumni<\/h4>\n

Cultimate Foods<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Cultimate\n <\/div>\n
\n

Cultimate Foods creates a game-changing ingredient based on cultivated fat in a sustainable and ethical way.
\nTheir unique solution enriches plant-based meat alternatives with authentic taste, mouthfeel, and texture. They believe that the future of meat is hybrid – a combination of plant-based proteins and their fat alternative product.<\/p>\n\n \n \n <\/span>mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n

\n
\n

lab user alumni<\/h4>\n

Ucaneo Biotech<\/h2>\n
<\/div>\n <\/div>\n
\n
\n \"Ucaneo\n <\/div>\n
\n

We are building the world’s first biotechnological Direct Air Capture (DAC) system with the goal to to capture 1% of the global CO2 emissions by 2035!<\/p>\n

Leveraging novel membranes and enzymes significantly reduces the energy consumption by lowering the conventional Direct Air Capture reaction temperature from up to 900\u00b0C to room temperature and avoiding active air intake. This enables massive cost savings and a sustainable reduction of CO2 in the atmosphere. <\/p>\n

Using the most modern equipment and S1 lab as well as the makerspace we found the perfect place at the Life Science Factory to develop our biotech hardware solution.<\/p>\n\n \n \n <\/span>Mehr erfahren<\/span>\n <\/a>\n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n<\/div>\n\n\n\n

\n\n\n
\n
\n

Jobangebote in unserer Community<\/h2>\n <\/div>\n <\/div>\n \n\n \n<\/div>\n\n\n\n
\n\n\n
\n
\n\n\n
\n\n\n
\n

RN.AI\u00a0Therapeutics<\/span><\/h3>\n <\/div>\n \n \n
\n\n\n \n\n \n
\n

Cell Biology and Immunology Scientist<\/a><\/p>\n

COPD and Asthma Preclinical Scientist<\/a><\/p>\n

AI Scientist<\/a><\/p>\n

 <\/p>\n <\/div>\n \n\n \n \n \n\n \n \n\n \n\n <\/div>\n \n\n <\/div>\n\n\n <\/div>\n <\/div>\n\n\n<\/div>\n\n\n\n

\n\n\n
\n
\n\n\n
\n\n\n
\n

proteinea<\/span><\/h3>\n <\/div>\n \n \n
\n\n\n \n\n \n
\n

Research Associate\/Scientist – In Vitro Immune Assays<\/a>  <\/p>\n

Research Associate\/Scientist – Flow Cytometry Specialist & Antibody Research<\/a><\/p>\n <\/div>\n \n\n \n \n \n\n \n \n\n \n\n <\/div>\n \n\n <\/div>\n\n\n <\/div>\n <\/div>\n\n\n<\/div>\n\n\n\n

\n\n\n
\n
\n\n\n
\n\n\n
\n

Transfer- und Gr\u00fcndungsservice Martin-Luther-Universit\u00e4t – Projekt RNA PROTECT<\/span><\/h3>\n <\/div>\n \n \n
\n\n\n \n\n \n
\n

Business Development Manager*in als Co-Founder*in<\/a><\/p>\n <\/div>\n \n\n \n \n \n\n \n \n\n \n\n <\/div>\n \n\n <\/div>\n\n\n <\/div>\n <\/div>\n\n\n<\/div>\n\n\n\n

\n\n
\n
\n
\n

get in touch with our mentors<\/h2>\n <\/div>\n <\/div>\n
\n
\n

Erhalte fachkundige Unterst\u00fctzung durch unsere Mentoren und Investoren. Gerade Start-ups in einer fr\u00fchen Phase ben\u00f6tigen bedarfsgerechte Unterst\u00fctzung bei ihren Herausforderungen. Unsere Experten sind selbst erfolgreiche Life-Science-Gr\u00fcnder*innen, Investoren oder Wissenschaftler*innen, die begeistert ihre spezifischen Fachkenntnisse teilen und helfen innovative Projekte nachhaltig aufzubauen. <\/p>\n <\/div>\n <\/div>\n <\/div>\n \n \n<\/div>\n\n\n\n

\n\n \n\n
\n\n \n \n
\n\n\n
\n \n \"Person\n <\/a>\n <\/div>\n \n\n

Dr. Grit Zahn<\/h3>\n \n\n

Head of Research at Eternygen GmbH I Drug Development, Company building, technology transfer<\/h5>\n \n\n

Grit ist Biochemikerin und arbeitet seit mehr als 20 Jahren im Drug Development. Dabei hat sie schon in verschiedenen Institutionen und Firmen gearbeitet, angefangen in der Forschung an der Charit\u00e9 in Berlin, in der Medikamentenentwicklung beim BioTechunternehmen Jerini AG, was ein Produkt bis zur Marktreife entwickelt hat, im Technologietransfer bei der ipal GmbH bis hin zur Eternygen GmbH. Hier ist sie als Head of Research t\u00e4tig und ber\u00e4t dar\u00fcber hinaus auch weitere Biotechunternehmen.<\/p>\n\n\n <\/span>LinkedIn Profil Grit Zahn<\/span><\/a>\n \n <\/div>\n \n

\n\n\n
\n \n \"Portrait\"\n\n <\/a>\n <\/div>\n \n\n

Julia Schomburg<\/h3>\n \n\n

Investment Manager at Arkadien Finanz I Investor Readiness, Business Structure, Team Development<\/h5>\n \n\n

Julia Schomburg ist Kommunikations\u00f6konomin und war mehrere Jahre in Werbeagenturen t\u00e4tig. Seit \u00fcber 15 Jahren bringt sie ihre Erfahrung als Investment Managerin bei Arkadien Finanz ein. Mit ihrem umfassenden Branchenwissen unterst\u00fctzt sie Start-ups vor allem in den Bereichen Investor Readiness, Gesch\u00e4ftsaufbau und Teamentwicklung.<\/p>\n\n\n <\/span>LinkedIn Profil Julia Schomburg<\/span><\/a>\n \n <\/div>\n \n

\n\n\n
\n \n \"Portrait\"\n\n <\/a>\n <\/div>\n \n\n

Daniel Schuppmann<\/h3>\n \n\n

Lawyer for IP & Tech Law at NEUWERK I Life Sciences, Licensing, Product Development Support<\/h5>\n \n\n

Daniel ist Jurist und ber\u00e4t umfassend zu Fragen des Technologie- und geistigen Eigentumsrechts, Datenschutzes sowie zu vertraglichen Themen. Sein Schwerpunkt liegt auf der Unterst\u00fctzung von Life-Science-Unternehmen \u2013 insbesondere beim Schutz und der Lizenzierung ihrer Technologien sowie bei der rechtlichen Begleitung entlang des gesamten Produktentwicklungszyklus.<\/p>\n\n\n <\/span>LinkedIn Profil Daniel Schuppmann<\/span><\/a>\n \n <\/div>\n <\/div>\n \n\n<\/div>\n\n\n\n\n

\n
\n\n
\n\n
\n\n
\n

mehr erfahren?<\/h2>\n <\/div>\n\n
\n

Dann schlie\u00dfe ein Community Ticket ab und erhalte Zugang zu dem kompletten Netzwerk.<\/p>\n <\/div>\n\n

\n <\/span>Angebot<\/span><\/a>\n <\/div>\n\n <\/div>\n\n <\/div>\n\n <\/div>\n<\/div>\n\n\n\n\n\n\n
\n\n
\n
\n
\n

shoutout to our network and partners!<\/h2>\n <\/div>\n <\/div>\n <\/div>\n \n \n<\/div>\n\n\n\n
\n\n\n
\n
\n

partner<\/h2>\n <\/div>\n <\/div>\n \n\n \n<\/div>\n\n\n\n
\n\n \n
\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n <\/div>\n \n<\/div>\n\n\n\n
\n\n\n
\n
\n

netzwerk<\/h2>\n <\/div>\n <\/div>\n \n\n \n<\/div>\n\n\n\n
\n\n \n
\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Science\n <\/a>\n <\/div>\n
\n \n \"Lofo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n
\n \n \"Logo\n <\/a>\n <\/div>\n <\/div>\n \n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":36,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4329","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/pages\/4329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/comments?post=4329"}],"version-history":[{"count":262,"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/pages\/4329\/revisions"}],"predecessor-version":[{"id":191810,"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/pages\/4329\/revisions\/191810"}],"wp:attachment":[{"href":"https:\/\/lifescience-factory.com\/de\/wp-json\/wp\/v2\/media?parent=4329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}